John F. Maher

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Ru Zhou · 2 shared papers, 2019–2025 · strength 0.37
   • Paper Tumor-intrinsic interferon signaling drives pancreatic cancer resistance to tumor mucin1-targeted CAR T cell therapy. DOI 10.3389/fimmu.2025.1618415↗
   • Paper Overcoming Immunological Resistance Enhances the Efficacy of A Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic… DOI 10.3390/cells8091070↗
2. Pinku Mukherjee · 2 shared papers, 2019–2025 · strength 0.37
   • Paper Tumor-intrinsic interferon signaling drives pancreatic cancer resistance to tumor mucin1-targeted CAR T cell therapy. DOI 10.3389/fimmu.2025.1618415↗
   • Paper Overcoming Immunological Resistance Enhances the Efficacy of A Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic… DOI 10.3390/cells8091070↗
3. Lauren C. Cutmore · 1 shared paper, 2020 · strength 0.11
   • Paper Pancreatic Cancer UK Grand Challenge: Developments and challenges for effective CAR T cell therapy for pancreatic ducta… DOI 10.1016/j.pan.2020.02.006↗
4. Nicholas Fraser Brown · 1 shared paper, 2020 · strength 0.11
   • Paper Pancreatic Cancer UK Grand Challenge: Developments and challenges for effective CAR T cell therapy for pancreatic ducta… DOI 10.1016/j.pan.2020.02.006↗
5. Deepak Raj · 1 shared paper, 2020 · strength 0.11
   • Paper Pancreatic Cancer UK Grand Challenge: Developments and challenges for effective CAR T cell therapy for pancreatic ducta… DOI 10.1016/j.pan.2020.02.006↗
6. Yaohe Wang · 1 shared paper, 2020 · strength 0.11
   • Paper Pancreatic Cancer UK Grand Challenge: Developments and challenges for effective CAR T cell therapy for pancreatic ducta… DOI 10.1016/j.pan.2020.02.006↗
7. John F. Marshall · 1 shared paper, 2020 · strength 0.11
   • Paper Pancreatic Cancer UK Grand Challenge: Developments and challenges for effective CAR T cell therapy for pancreatic ducta… DOI 10.1016/j.pan.2020.02.006↗
8. Doraid Alrifai · 1 shared paper, 2016 · strength 0.10
   • Paper Prospects for adoptive immunotherapy of pancreatic cancer using chimeric antigen receptor-engineered T-cells. DOI 10.3109/08923973.2015.1100204↗
9. Debashis Sarker · 1 shared paper, 2016 · strength 0.10
   • Paper Prospects for adoptive immunotherapy of pancreatic cancer using chimeric antigen receptor-engineered T-cells. DOI 10.3109/08923973.2015.1100204↗
10. Priyanka Grover · 1 shared paper, 2019 · strength 0.09
    • Paper Overcoming Immunological Resistance Enhances the Efficacy of A Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic… DOI 10.3390/cells8091070↗
11. Mukulika Bose · 1 shared paper, 2019 · strength 0.09
    • Paper Overcoming Immunological Resistance Enhances the Efficacy of A Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic… DOI 10.3390/cells8091070↗
12. Shu-ta Wu · 1 shared paper, 2019 · strength 0.09
    • Paper Overcoming Immunological Resistance Enhances the Efficacy of A Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic… DOI 10.3390/cells8091070↗
13. Didier Dréau · 1 shared paper, 2019 · strength 0.09
    • Paper Overcoming Immunological Resistance Enhances the Efficacy of A Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic… DOI 10.3390/cells8091070↗
14. Mahboubeh Yazdanifar · 1 shared paper, 2019 · strength 0.09
    • Paper Overcoming Immunological Resistance Enhances the Efficacy of A Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic… DOI 10.3390/cells8091070↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.